News
Current position:Product Center > Cell lines > TAA > BCMA:BAFFR:TACI > H_BCMA CHO-K1 Cell Line
H_BCMA CHO-K1 Cell Line
Specifications
Cat. NoGM-C24849
ProductH_BCMA CHO-K1 Cell Line
DescriptionH_BCMA CHO-K1 Cell Line is a clonal stable CHO-K1 cell line that constitutively expresses the human BCMA gene, constructed using lentiviral technology.
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
TargetHuman_BCMA
Gene ID/Uniprot IDQ02223-1
Host CellCHO-K1
Recovery MediumF12K+10% FBS+1% P.S
Growth mediumF12K+10% FBS+1% P.S+4 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Data
H_BCMA CHO-K1 Cell Line (Cat. GM-C24849) was determined by flow cytometry using Anti-BCMA hIgG1 Antibody(Belantamab) (Cat. GM-52396AB).
Materials
ReagentOrdering Information
F12KBOSTER/PYG0036
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
PuromycinGenomeditech/GM-040401
Anti-BCMA hIgG1 Antibody(Belantamab)Genomeditech/GM-52396AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

 

Sequence

BCMA(TNFRSF17) Q02223-1
MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNAILWTCLGLSLIISLAVFVLMFLLRKINSEPLKDEFKNTGSGLLGMANIDLEKSRTGDEIILPRGLEYTVEECTCEDCIKSKPKVDSDHCFPLPAMEEGATILVTTKTNDYCKSLPAALSATEIEKSISAR*

Related Products
CD40:CD40L
H_CD40(TNFRSF5) Reporter 293 Cell LineH_CD40(TNFRSF5) Reporter Jurkat Cell LineCynomolgus_CD40 CHO-K1 Cell Line
Cynomolgus_CD40L CHO-K1 Cell LineH_CD40(TNFRSF5) CHO-K1 Cell LineH_CD40(TNFRSF5) HEK-293 Cell Line
H_CD40L CHO-K1 Cell LineH_CD40L HEK-293 Cell Line
Anti-H_CD40 hIgG1 Antibody(APX005M)Anti-H_CD40 hIgG1 Antibody(ravagalimab)Anti-H_CD40L hIgG1 Antibody(dapirolizumab)
Anti-H_CD40L hIgG1 Antibody(frexalimab)

Biotinylated Human CD40 Protein; His-Avi TagCynomolgus CD40 Protein; His TagHuman CD40 Protein; His Tag
Human CD40L Protein; His Tag

IFN-α
IFNα Reporter HEK-293 Cell LineIFNα Reporter MDCK Cell LineIFNα Reporter THP1 Cell Line
BCMA:BAFFR:TACI
H_BAFFR Jurkat Blockade Reporter Cell LineH_BAFFR Reporter Cell LineH_BCMA Reporter Cell Line
H_TACI Reporter Cell LineCynomolgus_BCMA CHO-K1 Cell LineH_BCMA HEK-293 Cell Line
Anti-BAFF hIgG1 Antibody(belimumab)Anti-BAFFR hIgG1 Antibody(ianalumab)Anti-BCMA hIgG1 Antibody(Belantamab)
Anti-BCMA hIgG1 Antibody(SEA-BCMA)Anti-BCMA hIgG4 Antibody(BCMB69)
Biotinylated Human BAFF Protein; His-Avi TagCynomolgus BAFF Protein; His TagHuman BAFF Protein; His Tag
Mouse BAFF Protein; His Tag

BDCA2(CLEC4C)
H_BDCA2 Reporter Jurkat Cell LineCynomolgus_BDCA2 CHO-K1 Cell LineCynomolgus_BDCA2 Jurkat Cell Line
H_BDCA2 CHO-K1 Cell LineH_BDCA2 HEK-293 Cell LineH_BDCA2 Jurkat Cell Line
Anti-H_BDCA2 hIgG1 Antibody(Litifilimab)

Cynomolgus BDCA2 Protein; His TagHuman BDCA2 Protein; His Tag
CD3
Jurkat CD3-BsAb Reporter Cell LineCynomolgus_CD3 HEK-293 Cell LineCynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
H_CD3 CHO-K1 Cell LineH_CD3 HEK-293 Cell LineH_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line

Anti-CD3 epsilon hIgG1 Antibody [OKT-3 (muromonab)]Anti-CD3 hIgG1 Antibody(CH2527)
Current Position:Product Center > Cell lines > TAA > BCMA:BAFFR:TACI > H_BCMA CHO-K1 Cell Line
classify
H_BCMA CHO-K1 Cell Line
Specifications
Cat. NoGM-C24849
ProductH_BCMA CHO-K1 Cell Line
DescriptionH_BCMA CHO-K1 Cell Line is a clonal stable CHO-K1 cell line that constitutively expresses the human BCMA gene, constructed using lentiviral technology.
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
TargetHuman_BCMA
Gene ID/Uniprot IDQ02223-1
Host CellCHO-K1
Recovery MediumF12K+10% FBS+1% P.S
Growth mediumF12K+10% FBS+1% P.S+4 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Data
H_BCMA CHO-K1 Cell Line (Cat. GM-C24849) was determined by flow cytometry using Anti-BCMA hIgG1 Antibody(Belantamab) (Cat. GM-52396AB).
Materials
ReagentOrdering Information
F12KBOSTER/PYG0036
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
PuromycinGenomeditech/GM-040401
Anti-BCMA hIgG1 Antibody(Belantamab)Genomeditech/GM-52396AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

 

Sequence

BCMA(TNFRSF17) Q02223-1
MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNAILWTCLGLSLIISLAVFVLMFLLRKINSEPLKDEFKNTGSGLLGMANIDLEKSRTGDEIILPRGLEYTVEECTCEDCIKSKPKVDSDHCFPLPAMEEGATILVTTKTNDYCKSLPAALSATEIEKSISAR*

Related Products
CD40:CD40L
H_CD40(TNFRSF5) Reporter 293 Cell LineH_CD40(TNFRSF5) Reporter Jurkat Cell LineCynomolgus_CD40 CHO-K1 Cell Line
Cynomolgus_CD40L CHO-K1 Cell LineH_CD40(TNFRSF5) CHO-K1 Cell LineH_CD40(TNFRSF5) HEK-293 Cell Line
H_CD40L CHO-K1 Cell LineH_CD40L HEK-293 Cell Line
Anti-H_CD40 hIgG1 Antibody(APX005M)Anti-H_CD40 hIgG1 Antibody(ravagalimab)Anti-H_CD40L hIgG1 Antibody(dapirolizumab)
Anti-H_CD40L hIgG1 Antibody(frexalimab)

Biotinylated Human CD40 Protein; His-Avi TagCynomolgus CD40 Protein; His TagHuman CD40 Protein; His Tag
Human CD40L Protein; His Tag

IFN-α
IFNα Reporter HEK-293 Cell LineIFNα Reporter MDCK Cell LineIFNα Reporter THP1 Cell Line
BCMA:BAFFR:TACI
H_BAFFR Jurkat Blockade Reporter Cell LineH_BAFFR Reporter Cell LineH_BCMA Reporter Cell Line
H_TACI Reporter Cell LineCynomolgus_BCMA CHO-K1 Cell LineH_BCMA HEK-293 Cell Line
Anti-BAFF hIgG1 Antibody(belimumab)Anti-BAFFR hIgG1 Antibody(ianalumab)Anti-BCMA hIgG1 Antibody(Belantamab)
Anti-BCMA hIgG1 Antibody(SEA-BCMA)Anti-BCMA hIgG4 Antibody(BCMB69)
Biotinylated Human BAFF Protein; His-Avi TagCynomolgus BAFF Protein; His TagHuman BAFF Protein; His Tag
Mouse BAFF Protein; His Tag

BDCA2(CLEC4C)
H_BDCA2 Reporter Jurkat Cell LineCynomolgus_BDCA2 CHO-K1 Cell LineCynomolgus_BDCA2 Jurkat Cell Line
H_BDCA2 CHO-K1 Cell LineH_BDCA2 HEK-293 Cell LineH_BDCA2 Jurkat Cell Line
Anti-H_BDCA2 hIgG1 Antibody(Litifilimab)

Cynomolgus BDCA2 Protein; His TagHuman BDCA2 Protein; His Tag
CD3
Jurkat CD3-BsAb Reporter Cell LineCynomolgus_CD3 HEK-293 Cell LineCynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
H_CD3 CHO-K1 Cell LineH_CD3 HEK-293 Cell LineH_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line

Anti-CD3 epsilon hIgG1 Antibody [OKT-3 (muromonab)]Anti-CD3 hIgG1 Antibody(CH2527)
Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit